FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 308 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL141371
NHLBI NIH HHS
Grant: R01 HL145676
NHLBI NIH HHS
Grant: R01 HL130020
NIBIB NIH HHS
Grant: T32 EB009035
NHLBI NIH HHS
Grant: R01 HL141851
NHLBI NIH HHS
Grant: R01 HL146690
National Institutes of Health
Grant: 2T32EB009035-16
Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford
National Institutes of Health
Grant: 2R01HL145676-05
Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation
National Institutes of Health
Grant: 3R01HL130020-07S1
Elucidating Genotype-Phenotype Relationship of Polygenic Dilated Cardiomyopathies
National Institutes of Health
Grant: 1R01HL146690-01
Genetic and Stem Cell Model of Cardiac Metabolic Disease
National Institutes of Health
Grant: 5R01HL141851-07
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
National Institutes of Health
Grant: 1R01HL141371-01
Human iPSC Model for Elucidating Crosstalk Signaling and Secretomes
MeSH Terms
Keywords